Epigenetic mechanisms in microbial members of the human microbiota: Current knowledge and perspectives

Epigenomics

Volumn 8, Issue 9, 2016, Pages 1259-1273

  Cureau, Natacha ^a   Aljahdali, Nesreen ^a   Vo, Nguyen ^a   Carbonero, Franck ^a  

^a UNIVERSITY OF ARKANSAS   (United States)

Author keywords

DNA methylation; epigenetics; human microbiota

Indexed keywords

AG43 PROTEIN; BACTERIAL PROTEIN; O ANTIGEN; OUTER MEMBRANE PROTEIN; UNCLASSIFIED DRUG; BACTERIAL DNA;

BACTERIAL GENETICS; BACTERIAL VIRULENCE; CHEMICAL MODIFICATION; COMMENSAL; DNA METHYLATION; ENTEROAGGREGATIVE ESCHERICHIA COLI; EPIGENETICS; EUKARYOTE; GENE CLUSTER; GENE SWITCHING; GENETIC REGULATION; HOST; HUMAN; INTESTINE FLORA; MICROBIAL COMMUNITY; NONHUMAN; OPERON; PATHOGENESIS; PRIORITY JOURNAL; PYELONEPHRITIS; REGULATORY MECHANISM; REVIEW; SALMONELLA ENTERICA; TYPE VI SECRETION SYSTEM; UROPATHOGENIC ESCHERICHIA COLI; GENETIC EPIGENESIS; GENETICS;

DNA METHYLATION; DNA, BACTERIAL; EPIGENESIS, GENETIC; GASTROINTESTINAL MICROBIOME; HUMANS;

EID: 84986907186     PISSN: 17501911     EISSN: 1750192X     Source Type: Journal    
DOI: 10.2217/epi-2016-0057     Document Type: Review

References (166)

1. Ley RE, Knight R, Gordon JI. The human microbiome: eliminating the biomedical/environmental dichotomy in microbial ecology. Environ. Microbiol. 9(1), 3-4 (2007).
2. Turnbaugh PJ, Ley RE, Hamady M, Fraser-Liggett CM, Knight R, Gordon JI. The human microbiome project. Nature 449(7164), 804-810 (2007).
3. Gill SR, Pop M, Deboy RT et al. Metagenomic analysis of the human distal gut microbiome. Science 312(5778), 1355-1359 (2006).
4. Turnbaugh PJ, Hamady M, Yatsunenko T et al. A core gut microbiome in obese and lean twins. Nature 457(7228), 480-484 (2009).
5. Kuczynski J, Costello EK, Nemergut DR et al. Direct sequencing of the human microbiome readily reveals community differences. Genome Biol. 11(5), 210 (2010).
6. Kostic AD, Xavier RJ, Gevers D. The microbiome in inflammatory bowel disease: current status and the future ahead. Gastroenterology 146(6), 1489-1499 (2014).
7. Candela M, Turroni S, Biagi E et al. Inflammation and colorectal cancer, when microbiota-host mutualism breaks. World J. Gastroenterol. 20(4), 908-922 (2014).
8. Everard A, Cani PD. Diabetes obesity and gut microbiota. Best Pract. Res. Clin. Gastroenterol. 27(1), 73-83 (2013).
9. Turnbaugh PJ, Ley RE, Mahowald MA, Magrini V, Mardis ER, Gordon JI. An obesity-associated gut microbiome with increased capacity for energy harvest. Nature 444(7122), 1027-1031 (2006).
10. Flint HJ. Obesity and the gut microbiota. J. Clin. Gastroenterol. (Suppl. 45), S128-S132 (2011).
11. Turnbaugh PJ, Gordon JI. The core gut microbiome, energy balance and obesity. J. Physiol. 587(Pt 17), 4153-4158 (2009).
12. Foster JA, McVey Neufeld KA. Gut-brain axis: how the microbiome influences anxiety and depression. Trends Neurosci. 36(5), 305-312 (2013).
13. Cryan JF, Dinan TG. Mind-altering microorganisms: the impact of the gut microbiota on brain and behaviour. Nat. Rev. Neurosci. 13(10), 701-712 (2012).
14. Collins SM, Surette M, Bercik P. The interplay between the intestinal microbiota and the brain. Nat. Rev. Microbiol. 10(11), 735-742 (2012).
15. El Aidy S, Kunze W, Bienenstock J, Kleerebezem M. The microbiota and the gut-brain axis: insights from the temporal and spatial mucosal alterations during colonisation of the germfree mouse intestine. Benef. Microbes 3(4), 251-259 (2012).
16. Kang DW, Park JG, Ilhan ZE et al. Reduced incidence of Prevotella and other fermenters in intestinal microflora of autistic children. PLoS ONE 8(7), e68322 (2013).
17. Yeoman CJ, Thomas SM, Miller ME et al. A multi-omic systems-based approach reveals metabolic markers of bacterial vaginosis and insight into the disease. PLoS ONE 8(2), e56111 (2013).
18. Walther-Antonio MR, Jeraldo P, Berg Miller ME et al. Pregnancy's stronghold on the vaginal microbiome. PLoS ONE 9(6), e98514 (2014).
19. White BA, Creedon DJ, Nelson KE, Wilson BA. The vaginal microbiome in health and disease. Trends Endocrinol. Metab. 22(10), 389-393 (2011).
20. Hickey RJ, Zhou X, Pierson JD, Ravel J, Forney LJ. Understanding vaginal microbiome complexity from an ecological perspective. Transl. Res. 160(4), 267-282 (2012).
21. Hickey RJ, Zhou X, Settles ML et al. Vaginal microbiota of adolescent girls prior to the onset of menarche resemble those of reproductive-age women. Mbio 6(2), pii: e00097-15 (2015).
22. San Miguel A, Grice EA. Interactions between host factors and the skin microbiome. Cell Mol. Life Sci. 72(8), 1499-1515 (2015).
23. Belkaid Y, Segre JA. Dialogue between skin microbiota and immunity. Science 346(6212), 954-959 (2014).
24. Koren O, Spor A, Felin J et al. Human oral, gut, and plaque microbiota in patients with atherosclerosis. Proc. Natl Acad. Sci. USA 108(Suppl. 1), 4592-4598 (2011).
25. Caporaso JG, Lauber CL, Costello EK et al. Moving pictures of the human microbiome. Genome Biol. 12(5), R50 (2011).
26. Duran-Pinedo AE, Frias-Lopez J. Beyond microbial community composition: functional activities of the oral microbiome in health and disease. Microbes Infect. 17(7), 505-516 (2015).
27. Ganesh BP, Klopfleisch R, Loh G, Blaut M. Commensal Akkermansia muciniphila exacerbates gut inflammation in Salmonella Typhimurium-infected gnotobiotic mice. PLoS ONE 8(9), e74963 (2013).
28. Devkota S, Wang Y, Musch MW et al. Dietary-fat-induced taurocholic acid promotes pathobiont expansion and colitis in Il10-/- mice. Nature 487(7405), 104-108 (2012).
29. Espley RV, Butts CA, Laing WA et al. Dietary flavonoids from modified apple reduce inflammation markers and modulate gut microbiota in mice. J. Nutr. 144(2), 146-154 (2014).
30. Turnbaugh PJ, Backhed F, Fulton L, Gordon JI. Dietinduced obesity is linked to marked but reversible alterations in the mouse distal gut microbiome. Cell. Host Microbe 3(4), 213-223 (2008).
31. Gomez A, Luckey D, Yeoman CJ et al. Loss of sex and age driven differences in the gut microbiome characterize arthritis-susceptible 0401 mice but not arthritis-resistant 0402 mice. PLoS ONE 7(4), e36095 (2012).
32. Kim HB, Borewicz K, White BA et al. Longitudinal investigation of the age-related bacterial diversity in the feces of commercial pigs. Vet. Microbiol. 153(1-2), 124-133 (2011).
33. Kim HB, Borewicz K, White BA et al. Microbial shifts in the swine distal gut in response to the treatment with antimicrobial growth promoter, tylosin. Proc. Natl Acad. Sci. USA 109(38), 15485-15490 (2012).
34. Schachtschneider KM, Yeoman CJ, Isaacson RE, White BA, Schook LB, Pieters M. Modulation of systemic immune responses through commensal gastrointestinal microbiota. PLoS ONE 8(1), e53969 (2013).
35. Moeller AH, Degnan PH, Pusey AE, Wilson ML, Hahn BH, Ochman H. Chimpanzees and humans harbour compositionally similar gut enterotypes. Nat. Commun. 3, 1179 (2012).
36. Ellis RJ, Bruce KD, Jenkins C et al. Comparison of the distal gut microbiota from people and animals in Africa. PLoS ONE 8(1), e54783 (2013).
37. Ochman H, Worobey M, Kuo CH et al. Evolutionary relationships of wild hominids recapitulated by gut microbial communities. PLoS Biol. 8(11), e1000546 (2010).
38. Amato KR, Yeoman CJ, Kent A et al. Habitat degradation impacts black howler monkey (Alouatta pigra) gastrointestinal microbiomes. ISME J. 7(7), 1344-1353 (2013).
39. Moeller AH, Peeters M, Ndjango JB, Li Y, Hahn BH, Ochman H. Sympatric chimpanzees and gorillas harbor convergent gut microbial communities. Genome Res. 23(10), 1715-1720 (2013).
40. Yildirim S, Yeoman CJ, Sipos M et al. Characterization of the fecal microbiome from non-human wild primates reveals species specific microbial communities. PLoS ONE 5(11), e13963 (2010).
41. Swanson KS, Dowd SE, Suchodolski JS et al. Phylogenetic and gene-centric metagenomics of the canine intestinal microbiome reveals similarities with humans and mice. ISME J. 5(4), 639-649 (2011).
42. Middelbos IS, Vester Boler BM, Qu A, White BA, Swanson KS, Fahey GC Jr. Phylogenetic characterization of fecal microbial communities of dogs fed diets with or without supplemental dietary fiber using 454 pyrosequencing. PLoS ONE 5(3), e9768 (2010).
43. Alyea RA, Gollapudi BB, Rasoulpour RJ. Are we ready to consider transgenerational epigenetic effects in human health risk assessment? Environ. Mol. Mutagen. 55(3), 292-298 (2014).
44. Kanherkar RR, Bhatia-Dey N, Makarev E, Csoka AB. Cellular reprogramming for understanding and treating human disease. Front. Cell. Dev. Biol. 2, 67 (2014).
45. Feinberg AP. Phenotypic plasticity and the epigenetics of human disease. Nature 447(7143), 433-440 (2007).
46. Dolinoy DC, Jirtle RL. Environmental epigenomics in human health and disease. Environ. Mol. Mutagen. 49(1), 4-8 (2008).
47. Portela A, Esteller M. Epigenetic modifications and human disease. Nat. Biotechnol. 28(10), 1057-1068 (2010).
48. Issa JP, Baylin SB. Epigenetics and human disease. Nat. Med. 2(3), 281-282 (1996).
49. Jiang YH, Bressler J, Beaud et al. Epigenetics and human disease. Annu. Rev. Genomics Hum. Genet. 5, 479-510 (2004).
50. Zoghbi HY, Beaud et al. Epigenetics and human disease. Cold Spring Harb. Perspect. Biol. 8(2), a019497 (2016).
51. Kalish JM, Jiang C, Bartolomei MS. Epigenetics and imprinting in human disease. Int. J. Dev. Biol. 58(2-4), 291-298 (2014).
52. Egger G, Liang G, Aparicio A, Jones PA. Epigenetics in human disease and prospects for epigenetic therapy. Nature 429(6990), 457-463 (2004).
53. Jirtle RL. Epigenome: the program for human health and disease. Epigenomics 1(1), 13-16 (2009).
54. Jenke AC, Zilbauer M. Epigenetics in inflammatory bowel disease. Curr. Opin. Gastroenterol. 28(6), 577-584 (2012).
55. Loddo I, Romano C. Inflammatory bowel disease: genetics, epigenetics, and pathogenesis. Front. Immunol. 6, 551 (2015).
56. Okugawa Y, Grady WM, Goel A. Epigenetic alterations in colorectal cancer: emerging biomarkers. Gastroenterology 149(5), 1204-1225.e12 (2015).
57. Hammoud SS, Cairns BR, Jones DA. Epigenetic regulation of colon cancer and intestinal stem cells. Curr. Opin. Cell Biol. 25(2), 177-183 (2013).
58. Wilkinson J. Epigenome enhancer profiling reveals signature for colon cancer. Epigenomics 4(3), 248 (2012).
59. Quarta C, Schneider R, Tschop MH. Epigenetic ON/OFF switches for obesity. Cell 164(3), 341-342 (2016).
60. Greenhill C. Epigenetics: obesity-induced hypermethylation of adiponectin gene. Nat. Rev. Endocrinol. 11(9), 504 (2015).
61. Koch L. Epigenomics: sperm as obesity propagator? Nat. Rev. Genet. 17(1), 6 (2016).
62. Ronn T, Ling C. DNA methylation as a diagnostic and therapeutic target in the battle against Type 2 diabetes. Epigenomics 7(3), 451-460 (2015).
63. Smith CJ, Ryckman KK. Epigenetic and developmental influences on the risk of obesity, diabetes, and metabolic syndrome. Diabetes Metab. Syndr. Obes. 8, 295-302 (2015).
64. Pasquier J, Hoarau-Vechot J, Fakhro K, Rafii A, Abi Khalil C. Epigenetics and cardiovascular disease in diabetes. Curr. Diab Rep. 15(12), 108 (2015).
65. Mather KA, Kwok JB, Armstrong N, Sachdev PS. The role of epigenetics in cognitive ageing. Int. J. Geriatr. Psychiatry 29(11), 1162-1171 (2014).
66. Rudenko A, Tsai LH. Epigenetic regulation in memory and cognitive disorders. Neuroscience 264, 51-63 (2014).
67. Abdolmaleky HM, Zhou JR, Thiagalingam S. An update on the epigenetics of psychotic diseases and autism. Epigenomics 7(3), 427-449 (2015).
68. Berko ER, Greally JM. How might epigenetic dysregulation in early embryonic life contribute to autism spectrum disorder? Epigenomics 7(1), 1-4 (2015).
69. Loke YJ, Hannan AJ, Craig JM. The role of epigenetic change in autism spectrum disorders. Front. Neurol. 6, 107 (2015).
70. Calcagno DQ, Gigek CO, Chen ES, Burbano RR, Smith Mde A. DNA and histone methylation in gastric carcinogenesis. World J. Gastroenterol. 19(8), 1182-1192 (2013).
71. Alam H, Gu B, Lee MG. Histone methylation modifiers in cellular signaling pathways. Cell Mol. Life Sci. 72(23), 4577-4592 (2015).
72. Lawrence M, Daujat S, Schneider R. Lateral thinking: how histone modifications regulate gene expression. Trends Genet. 32(1), 42-56 (2016).
73. Annunziato AT. The Fork in the road: histone partitioning during DNA replication. Genes (Basel) 6(2), 353-371 (2015).
74. Liu J, Jia G. Methylation modifications in eukaryotic messenger RNA. J. Genet. Genomics 41(1), 21-33 (2014).
75. He Y, Ecker JR. Non-CG methylation in the human genome. Annu. Rev. Genomics Hum. Genet. 16, 55-77 (2015).
76. Hamidi T, Singh AK, Chen T. Genetic alterations of DNA methylation machinery in human diseases. Epigenomics 7(2), 247-265 (2015).
77. Roundtree IA, He C. RNA epigenetics-chemical messages for posttranscriptional gene regulation. Curr. Opin. Chem. Biol. 30, 46-51 (2016).
78. Dubnau D, Losick R. Bistability in bacteria. Mol. Microbiol. 61(3), 564-572 (2006).
79. Novick A, Weiner M. Enzyme induction as an all-or-none phenomenon. Proc. Natl Acad. Sci. USA 43(7), 553-566 (1957).
80. Keren I, Shah D, Spoering A, Kaldalu N, Lewis K. Specialized persister cells and the mechanism of multidrug tolerance in Escherichia coli. J. Bacteriol. 186(24), 8172-8180 (2004).
81. Moyed HS, Bertrand KP. hipA a newly recognized gene of Escherichia coli K-12 that affects frequency of persistence after inhibition of murein synthesis. J. Bacteriol. 155(2), 768-775 (1983).
82. Chen I, Christie PJ, Dubnau D. The ins and outs of DNA transfer in bacteria. Science 310(5753), 1456-1460 (2005).
83. Maamar H, Dubnau D. Bistability in the Bacillus subtilis K-state (competence) system requires a positive feedback loop. Mol. Microbiol. 56(3), 615-624 (2005).
84. Veening JW, Hamoen LW, Kuipers OP. Phosphatases modulate the bistable sporulation gene expression pattern in Bacillus subtilis. Mol. Microbiol. 56(6), 1481-1494 (2005).
85. Gonzalez-Pastor JE, Hobbs EC, Losick R. Cannibalism by sporulating bacteria. Science 301(5632), 510-513 (2003).
86. Skerker JM, Laub MT. Cell-cycle progression and the generation of asymmetry in Caulobacter crescentus. Nat. Rev. Microbiol. 2(4), 325-337 (2004).
87. Kumar R, Rao DN. Role of DNA methyltransferases in epigenetic regulation in bacteria. Subcell. Biochem. 61, 81-102 (2013).
88. Balleza E, Lopez-Bojorquez LN, Martinez-Antonio A et al. Regulation by transcription factors in bacteria: beyond description. FEMS Microbiol. Rev. 33(1), 133-151 (2009).
89. Reisenauer A, Kahng LS, McCollum S, Shapiro L. Bacterial DNA methylation: a cell cycle regulator? J. Bacteriol. 181(17), 5135-5139 (1999).
90. Casadesus J, Low DA. Programmed heterogeneity: epigenetic mechanisms in bacteria. J. Biol. Chem. 288(20), 13929-13935 (2013).
91. Casadesus J, Low D. Epigenetic gene regulation in the bacterial world. Microbiol. Mol. Biol. Rev. 70(3), 830-856 (2006).
92. Lopez-Garrido J, Casadesus J. Crosstalk between virulence loci: regulation of Salmonella enterica pathogenicity island 1 (SPI-1) by products of the std fimbrial operon. PLoS ONE 7(1), e30499 (2012).
93. Lopez-Garrido J, Casadesus J. The DamX protein of Escherichia coli and Salmonella enterica. Gut Microbes 1(4), 285-288 (2010).
94. Bogomolnaya LM, Santiviago CA, Yang HJ, Baumler AJ, Andrews-Polymenis HL. 'Form variation' of the O12 antigen is critical for persistence of Salmonella Typhimurium in the murine intestine. Mol. Microbiol. 70(5), 1105-1119 (2008).
95. Broadbent SE, Davies MR, van der Woude MW. Phase variation controls expression of Salmonella lipopolysaccharide modification genes by a DNA methylation-dependent mechanism. Mol. Microbiol. 77(2), 337-353 (2010).
96. Davies MR, Broadbent SE, Harris SR, Thomson NR, van der Woude MW. Horizontally acquired glycosyltransferase operons drive salmonellae lipopolysaccharide diversity. PLoS Genet. 9(6), e1003568 (2013).
97. Lerouge I, Vanderleyden J. O-antigen structural variation: mechanisms and possible roles in animal/plant-microbe interactions. FEMS Microbiol. Rev. 26(1), 17-47 (2002).
98. Blyn LB, Braaten BA, White-Ziegler CA, Rolfson DH, Low DA. Phase-variation of pyelonephritis-associated pili in Escherichia coli: evidence for transcriptional regulation. EMBO J. 8(2), 613-620 (1989).
99. Weyand NJ, Low DA. Regulation of Pap phase variation. Lrp is sufficient for the establishment of the phase OFF pap DNA methylation pattern and repression of pap transcription in vitro. J. Biol. Chem. 275(5), 3192-3200 (2000).
100. Danese PN, Pratt LA, Dove SL, Kolter R. The outer membrane protein, antigen 43, mediates cell-to-cell interactions within Escherichia coli biofilms. Mol. Microbiol. 37(2), 424-432 (2000).
101. Haagmans W, van der Woude M. Phase variation of Ag43 in Escherichia coli: Dam-dependent methylation abrogates OxyR binding and OxyR-mediated repression of transcription. Mol. Microbiol. 35(4), 877-887 (2000).
102. Ulett GC, Valle J, Beloin C, Sherlock O, Ghigo JM, Schembri MA. Functional analysis of antigen 43 in uropathogenic Escherichia coli reveals a role in long-term persistence in the urinary tract. Infect. Immun. 75(7), 3233-3244 (2007).
103. van der Woude MW, Henderson IR. Regulation and function of Ag43 (flu). Annu. Rev. Microbiol. 62, 153-169 (2008).
104. Wallecha A, Munster V, Correnti J, Chan T, van der Woude M. Dam- and OxyR-dependent phase variation of agn43: essential elements and evidence for a new role of DNA methylation. J. Bacteriol. 184(12), 3338-3347 (2002).
105. Brunet YR, Bernard CS, Gavioli M, Lloubes R, Cascales E. An epigenetic switch involving overlapping fur and DNA methylation optimizes expression of a type VI secretion gene cluster. PLoS Genet. 7(7), e1002205 (2011).
106. Coulthurst SJ. The type VI secretion system - a widespread and versatile cell targeting system. Res. Microbiol. 164(6), 640-654 (2013).
107. Schwarz S, Hood RD, Mougous JD. What is type VI secretion doing in all those bugs? Trends Microbiol. 18(12), 531-537 (2010).
108. Chen Z, Lewis KA, Shultzaberger RK et al. Discovery of Fur binding site clusters in Escherichia coli by information theory models. Nucleic Acids Res. 35(20), 6762-6777 (2007).
109. Leonard MT, Davis-Richardson AG, Ardissone AN et al. The methylome of the gut microbiome: disparate Dam methylation patterns in intestinal Bacteroides dorei. Front. Microbiol. 5, 361 (2014).
110. Davis-Richardson AG, Triplett EW. A model for the role of gut bacteria in the development of autoimmunity for Type 1 diabetes. Diabetologia 58(7), 1386-1393 (2015).
111. O'Callaghan A, Bottacini F, O'Connell Motherway M, van Sinderen D. Pangenome analysis of Bifidobacterium longum and site-directed mutagenesis through by-pass of restrictionmodification systems. BMC Genomics 16(1), 832-015-1968-4 (2015).
112. Cui L, Morris A, Ghedin E. The human mycobiome in health and disease. Genome Med. 5(7), 63 (2013).
113. Huffnagle GB, Noverr MC. The emerging world of the fungal microbiome. Trends Microbiol. 21(7), 334-341 (2013).
114. Seed PC. The human mycobiome. Cold Spring Harb. Perspect. Med. 5(5), a019810 (2014).
115. Suhr MJ, Hallen-Adams HE. The human gut mycobiome: pitfalls and potentials - a mycologist's perspective. Mycologia 107(6), 1057-1073 (2015).
116. Gouba N, Drancourt M. Digestive tract mycobiota: a source of infection. Med. Mal. Infect. 45(1-2), 9-16 (2015).
117. Mar Rodriguez M, Perez D, Javier Chaves F et al. Obesity changes the human gut mycobiome. Sci. Rep. 5, 14600 (2015).
118. Moyes DL, Naglik JR. The mycobiome: influencing IBD severity. Cell. Host Microbe 11(6), 551-552 (2012).
119. Mukherjee PK, Sendid B, Hoarau G, Colombel JF, Poulain D, Ghannoum MA. Mycobiota in gastrointestinal diseases. Nat. Rev. Gastroenterol. Hepatol. 12(2), 77-87 (2015).
120. Suhr MJ, Banjara N, Hallen-Adams HE. Sequence-based methods for detecting and evaluating the human gut mycobiome. Lett. Appl. Microbiol. 62(3), 209-215 (2015).
121. Tang J, Iliev ID, Brown J, Underhill DM, Funari VA. Mycobiome: approaches to analysis of intestinal fungi. J. Immunol. Methods 421, 112-121 (2015).
122. Wang ZK, Yang YS, Stefka AT, Sun G, Peng LH. Review article: fungal microbiota and digestive diseases. Aliment. Pharmacol. Ther. 39(8), 751-766 (2014).
123. Diaz PI, Strausbaugh LD, Dongari-Bagtzoglou A. Fungal-bacterial interactions and their relevance to oral health: linking the clinic and the bench. Front. Cell. Infect. Microbiol. 4, 101 (2014).
124. Dupuy AK, David MS, Li L et al. Redefining the human oral mycobiome with improved practices in ampliconbased taxonomy: discovery of Malassezia as a prominent commensal. PLoS ONE 9(3), e90899 (2014).
125. Ghannoum MA, Jurevic RJ, Mukherjee PK et al. Characterization of the oral fungal microbiome (mycobiome) in healthy individuals. PLoS Pathog. 6(1), e1000713 (2010).
126. Cui L, Lucht L, Tipton L et al. Topographic diversity of the respiratory tract mycobiome and alteration in HIV and lung disease. Am. J. Respir. Crit. Care Med. 191(8), 932-942 (2015).
127. Jung WH, Croll D, Cho JH, Kim YR, Lee YW. Analysis of the nasal vestibule mycobiome in patients with allergic rhinitis. Mycoses 58(3), 167-172 (2015).
128. Kramer R, Sauer-Heilborn A, Welte T, Guzman CA, Abraham WR, Hofle MG. Cohort study of airway mycobiome in adult cystic fibrosis patients: differences in community structure between fungi and bacteria reveal predominance of transient fungal elements. J. Clin. Microbiol. 53(9), 2900-2907 (2015).
129. Nguyen LD, Viscogliosi E, Delhaes L. The lung mycobiome: an emerging field of the human respiratory microbiome. Front. Microbiol. 6, 89 (2015).
130. Park HK, Ha MH, Park SG, Kim MN, Kim BJ, Kim W. Characterization of the fungal microbiota (mycobiome) in healthy and dandruff-afflicted human scalps. PLoS ONE 7(2), e32847 (2012).
131. Wu G, Zhao H, Li C et al. Genus-wide comparative genomics of Malassezia delineates its phylogeny, physiology, and niche adaptation on human skin. PLoS Genet. 11(11), e1005614 (2015).
132. Grunstein M, Gasser SM. Epigenetics in Saccharomyces cerevisiae. Cold Spring Harb. Perspect. Biol. 5(7), pii: a017491 (2013).
133. Sneppen K, Dodd IB. Cooperative stabilization of the SIR complex provides robust epigenetic memory in a model of SIR silencing in Saccharomyces cerevisiae. Epigenetics 10(4), 293-302 (2015).
134. Dodson AE, Rine J. Heritable capture of heterochromatin dynamics in Saccharomyces cerevisiae. Elife 4, e05007 (2015).
135. McClure JM, Gallo CM, Smith DL Jr et al. Pnc1p-mediated nicotinamide clearance modifies the epigenetic properties of rDNA silencing in Saccharomyces cerevisiae. Genetics 180(2), 797-810 (2008).
136. Feng SY, Ota K, Ito T. A yeast one-hybrid system to screen for methylated DNA-binding proteins. Nucleic Acids Res. 38(20), e189 (2010).
137. Azad GK, Tomar RS. Partial purification of histone H3 proteolytic activity from budding yeast Saccharomyces cerevisiae. Yeast 33(6), 217-226 (2016).
138. Antczak AJ, Tsubota T, Kaufman PD, Berger JM. Structure of the yeast histone H3-ASF1 interaction: implications for chaperone mechanism, species-specific interactions, and epigenetics. BMC Struct. Biol. 6, 26 (2006).
139. Chavez MS, Scorgie JK, Dennehey BK, Noone S, Tyler JK, Churchill ME. The conformational flexibility of the C-terminus of histone H4 promotes histone octamer and nucleosome stability and yeast viability. Epigenetics Chromatin 5(1), 5 (2012).
140. Andersen LO, Vedel Nielsen H, Stensvold CR. Waiting for the human intestinal eukaryotome. ISME J. 7(7), 1253-1255 (2013).
141. Parfrey LW, Walters WA, Lauber CL et al. Communities of microbial eukaryotes in the mammalian gut within the context of environmental eukaryotic diversity. Front. Microbiol. 5, 298 (2014).
142. Parfrey LW, Walters WA, Knight R. Microbial eukaryotes in the human microbiome: ecology, evolution, and future directions. Front. Microbiol. 2, 153 (2011).
143. Wegener Parfrey L. Mock communities highlight the diversity of host-associated eukaryotes. Mol. Ecol. 24(17), 4337-4339 (2015).
144. Foda BM, Singh U. Dimethylated H3K27 Is a repressive epigenetic histone mark in the protist Entamoeba histolytica and is significantly enriched in genes silenced via the RNAi pathway. J. Biol. Chem. 290(34), 21114-21130 (2015).
145. Tovy A, Ankri S. Epigenetics in the unicellular parasite Entamoeba histolytica. Future Microbiol. 5(12), 1875-1884 (2010).
146. Kumar H, Lund R, Laiho A et al. Gut microbiota as an epigenetic regulator: pilot study based on whole-genome methylation analysis. Mbio. 5(6), e02113-e02114 (2014).
147. Dalmasso G, Nguyen HT, Yan Y et al. Microbiota modulate host gene expression via microRNAs. PLoS ONE 6(4), e19293 (2011).
148. Kiga K, Mimuro H, Suzuki M et al. Epigenetic silencing of miR-210 increases the proliferation of gastric epithelium during chronic Helicobacter pylori infection. Nat. Commun. 5, 4497 (2014).
149. Ding SZ, Fischer W, Kaparakis-Liaskos M et al. Helicobacter pylori-induced histone modification, associated gene expression in gastric epithelial cells, and its implication in pathogenesis. PLoS ONE 5(4), e9875 (2010).
150. Maekita T, Nakazawa K, Mihara M et al. High levels of aberrant DNA methylation in Helicobacter pylori-infected gastric mucosae and its possible association with gastric cancer risk. Clin. Cancer Res. 12(3 Pt 1), 989-995 (2006).
151. Ando T, Yoshida T, Enomoto S et al. DNA methylation of microRNA genes in gastric mucosae of gastric cancer patients: its possible involvement in the formation of epigenetic field defect. Int. J. Cancer 124(10), 2367-2374 (2009).
152. Modak R, Das Mitra S, Vasudevan M et al. Epigenetic response in mice mastitis: role of histone H3 acetylation and microRNA(s) in the regulation of host inflammatory gene expression during Staphylococcus aureus infection. Clin. Epigenetics 6(1), 12 (2014).
153. Lawless N, Foroushani AB, McCabe MS, O'Farrelly C, Lynn DJ. Next generation sequencing reveals the expression of a unique miRNA profile in response to a Gram-positive bacterial infection. PLoS ONE 8(3), e57543 (2013).
154. Vanselow J, Yang W, Herrmann J et al. DNA-remethylation around a STAT5-binding enhancer in the alphaS1- casein promoter is associated with abrupt shutdown of alphaS1-casein synthesis during acute mastitis. J. Mol. Endocrinol. 37(3), 463-477 (2006).
155. Bobetsis YA, Barros SP, Lin DM et al. Bacterial infection promotes DNA hypermethylation. J. Dent. Res. 86(2), 169-174 (2007).
156. Drury JL, Chung WO. DNA methylation differentially regulates cytokine secretion in gingival epithelia in response to bacterial challenges. Pathog. Dis. 73(2), 1-6 (2015).
157. Berni Canani R, Di Costanzo M, Leone L. The epigenetic effects of butyrate: potential therapeutic implications for clinical practice. Clin. Epigenetics 4(1), 4 (2012).
158. Akhtar M, Cheng Y, Magno RM et al. Promoter methylation regulates Helicobacter pylori-stimulated cyclooxygenase-2 expression in gastric epithelial cells. Cancer Res. 61(6), 2399-2403 (2001).
159. Takahashi K, Sugi Y, Nakano K et al. Epigenetic control of the host gene by commensal bacteria in large intestinal epithelial cells. J. Biol. Chem. 286(41), 35755-35762 (2011).
160. Takahashi K, Sugi Y, Hosono A, Kaminogawa S. Epigenetic regulation of TLR4 gene expression in intestinal epithelial cells for the maintenance of intestinal homeostasis. J. Immunol. 183(10), 6522-6529 (2009).
161. Ghadimi D, Helwig U, Schrezenmeir J, Heller KJ, de Vrese M. Epigenetic imprinting by commensal probiotics inhibits the IL-23/IL-17 axis in an in vitro model of the intestinal mucosal immune system. J. Leukoc. Biol. 92(4), 895-911 (2012).
162. Lutay N, Ambite I, Gronberg Hernandez J et al. Bacterial control of host gene expression through RNA polymerase II. J. Clin. Invest. 123(6), 2366-2379 (2013).
163. Chernov AV, Reyes L, Xu Z et al. Mycoplasma CG- and GATC-specific DNA methyltransferases selectively and efficiently methylate the host genome and alter the epigenetic landscape in human cells. Epigenetics 10(4), 303-318 (2015).
164. Ou J, Carbonero F, Zoetendal EG et al. Diet, microbiota, and microbial metabolites in colon cancer risk in rural Africans and African Americans. Am. J. Clin. Nutr. 98(1), 111-120 (2013).
165. O'Keefe SJ, Li JV, Lahti L et al. Fat, fibre and cancer risk in African Americans and rural Africans. Nat. Commun. 6, 6342 (2015).
166. Hullar MA, Fu BC. Diet, the gut microbiome, and epigenetics. Cancer J. 20(3), 170-175 (2014).